Ajanta Pharma’s formulation facility at Dahej was inspected by US Food and Drug Administration (USFDA) from April 3 to April 7, 2017. At the end of the inspection, no Form 483 was issued to the company.
Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. The company is engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.